Skip to main content
logo
Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
3.650
+0.310 (9.28%)
At close: Aug 19, 2026, 4:00 PM EDT
3.620
-0.030 (-0.82%)
Pre-market: Aug 20, 2026, 8:48 AM EDT

Rocket Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-17.25-223.12-258.75-245.6-221.86-169.07
Depreciation & Amortization
9.7111.039.387.16.275.37
Other Amortization
-----0.75
Loss (Gain) From Sale of Assets
-178.19-----
Asset Writedown & Restructuring Costs
0.260.26-0.890.240.26
Loss (Gain) From Sale of Investments
-4.35-6.97-8.07-10.170.132.89
Stock-Based Compensation
31.7837.0643.9239.4131.0129.24
Other Operating Activities
---1.88-0.36-12.78
Change in Accounts Payable
-12.16-10.356.0710.159.67-4.83
Change in Other Net Operating Assets
-0.062.09-0.43.68-3.61.44
Operating Cash Flow
-170.27-190.01-209.72-194.92-178.14-121.16
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.13-0.44-5.86-16.44-8.36-7.62
Cash Acquisitions
----42.73-
Investment in Securities
183.79104.21137.57-81.59-103.4326.57
Other Investing Activities
----0.04-0.26-0.1
Investing Cash Flow
361.85103.77131.71-98.07-69.3318.85

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt Repaid
-0-----
Net Debt Issued (Repaid)
-0-----
Issuance of Common Stock
0.15-185.74208.4155.3437.68
Repurchase of Common Stock
-0.07-0.07---0.05-
Other Financing Activities
-0.22----
Financing Cash Flow
0.080.15185.74208.4155.2937.68

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
191.66-86.1107.72-84.58-92.18-64.63

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-170.39-190.45-215.59-211.35-186.5-128.78
Free Cash Flow Growth
------
Free Cash Flow Per Share
-1.52-1.71-2.27-2.52-2.74-2.04
Levered Free Cash Flow
86.14-104.85-133.26-119.77-99.45-82.57
Unlevered Free Cash Flow
87.32-103.67-132.08-118.6-98.29-81.47

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
-----0.15
Change in Working Capital
-12.23-8.265.6713.826.08-3.39
SEC Filings: 10-K · 10-Q